Unity Biotechnology, Inc. Sublease Income
Unity Biotechnology, Inc. reported Sublease Income of $847.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-04-22.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2025-04-22
- Unity Biotechnology, Inc. sublease income for the quarter ending 2025-03-31 was $847.00K, a 42.46% decline year-over-year.
- Unity Biotechnology, Inc. sublease income for the quarter ending 2024-12-31 was $848.00K, a 21.77% decline year-over-year.
- Unity Biotechnology, Inc. sublease income for the quarter ending 2024-09-30 was $1.07M, a 9.32% increase year-over-year.
- Unity Biotechnology, Inc. sublease income for the quarter ending 2024-06-30 was $1.47M, a 52.54% increase year-over-year.
- Unity Biotechnology, Inc. sublease income for fiscal 2024 was $4.86M, a 21.84% increase from fiscal 2023.
- Unity Biotechnology, Inc. sublease income for fiscal 2023 was $3.99M, a 7.62% decline from fiscal 2022.
- Unity Biotechnology, Inc. sublease income for fiscal 2022 was $4.32M, a 67.46% increase from fiscal 2021.
- Unity Biotechnology, Inc. sublease income for fiscal 2021 was $2.58M.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 6 month as first filed | Sublease Income 9 month | Sublease Income 12 month |
|---|---|---|---|---|---|
| 2025-03-31 | $847.00K 10-Q · filed 2025-04-22 | $1.70M derived: sum of 2 quarters · filed 2025-04-22 | $2.76M derived: sum of 3 quarters · filed 2025-04-22 | $4.23M derived: sum of 4 quarters · filed 2025-04-22 | |
| 2024-12-31 | $848.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $1.92M derived: sum of 2 quarters · filed 2025-03-07 | $3.39M derived: sum of 3 quarters · filed 2025-03-07 | $4.86M 10-K · filed 2025-03-07 | |
| 2024-09-30 | $1.07M 10-Q · filed 2024-11-04 | $2.54M derived: sum of 2 quarters · filed 2024-11-04 | $4.01M 10-Q · filed 2024-11-04 | $5.09M derived: sum of 4 quarters · filed 2025-04-22 | |
| 2024-06-30 | $1.47M 10-Q · filed 2024-08-06 | $2.94M 10-Q · filed 2024-08-06 | $4.03M derived: sum of 3 quarters · filed 2025-04-22 | $5.00M derived: sum of 4 quarters · filed 2025-04-22 | |
| 2024-03-31 | $1.47M 10-Q · filed 2025-04-22 | $2.56M derived: sum of 2 quarters · filed 2025-04-22 | $3.53M derived: sum of 3 quarters · filed 2025-04-22 | $4.50M derived: sum of 4 quarters · filed 2025-04-22 | |
| 2023-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.06M derived: sum of 2 quarters · filed 2025-03-07 | $3.02M derived: sum of 3 quarters · filed 2025-03-07 | $3.99M 10-K · filed 2025-03-07 | |
| 2023-09-30 | $976.00K 10-Q · filed 2024-11-04 | $1.94M derived: sum of 2 quarters · filed 2024-11-04 | $2.90M 10-Q · filed 2024-11-04 | $3.82M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2023-06-30 | $965.00K 10-Q · filed 2024-08-06 | $2.01M 10-Q · filed 2024-08-06 | $1.93M 10-Q · filed 2023-08-08 | $2.84M derived: sum of 3 quarters · filed 2025-03-07 | $4.23M derived: sum of 4 quarters · filed 2025-03-07 |
| 2023-03-31 | $963.00K 10-Q · filed 2024-05-14 | $1.88M derived: sum of 2 quarters · filed 2025-03-07 | $3.27M derived: sum of 3 quarters · filed 2025-03-07 | $4.23M derived: sum of 4 quarters · filed 2025-03-07 | |
| 2022-12-31 | $912.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $2.30M derived: sum of 2 quarters · filed 2025-03-07 | $3.27M derived: sum of 3 quarters · filed 2025-03-07 | $4.32M 10-K · filed 2025-03-07 | |
| 2022-09-30 | $1.39M 10-Q · filed 2023-11-13 | $2.36M derived: sum of 2 quarters · filed 2023-11-13 | $3.40M 10-Q · filed 2023-11-13 | $4.46M derived: sum of 4 quarters · filed 2024-04-15 | |
| 2022-06-30 | $966.00K 10-Q · filed 2023-08-08 | $2.01M 10-Q · filed 2023-08-08 | $3.07M derived: sum of 3 quarters · filed 2024-04-15 | $4.06M derived: sum of 4 quarters · filed 2024-04-15 | |
| 2022-03-31 | $1.05M 10-Q · filed 2023-05-09 | $2.10M derived: sum of 2 quarters · filed 2024-04-15 | $3.09M derived: sum of 3 quarters · filed 2024-04-15 | $3.48M derived: sum of 4 quarters · filed 2024-04-15 | |
| 2021-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-15 | $2.04M derived: sum of 2 quarters · filed 2024-04-15 | $2.43M derived: sum of 3 quarters · filed 2024-04-15 | $2.58M 10-K · filed 2024-04-15 | |
| 2021-09-30 | $986.00K 10-Q · filed 2022-11-08 | $1.38M derived: sum of 2 quarters · filed 2022-11-08 | $1.52M 10-Q · filed 2022-11-08 | ||
| 2021-06-30 | $390.00K 10-Q · filed 2022-08-12 | $535.00K 10-Q · filed 2022-08-12 | |||
| 2021-03-31 | $145.00K 10-Q · filed 2022-05-10 | ||||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-11 |